Volatile anesthetics for status asthmaticus in pediatric patients: A comprehensive review and case series

Paediatric Anaesthesia

Volumn 25, Issue 5, 2015, Pages 460-467

  Carrié, Sabrina ^a,b   Anderson, Thomas Anthony ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

asthma; isoflurane for status asthmaticus; pediatrics; refractory asthma; status asthmaticus; volatile anesthetics

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DESFLURANE; HALOTHANE; HELIOX; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MAGNESIUM SULFATE; METHYLXANTHINE DERIVATIVE; PROPOFOL; SALBUTAMOL; SEVOFLURANE; TERBUTALINE; THEOPHYLLINE; ANTIASTHMATIC AGENT;

ASTHMA; ASTHMATIC STATE; BRONCHOCONSTRICTION; CLINICAL EVALUATION; DRUG MECHANISM; EXTRACORPOREAL OXYGENATION; HUMAN; INTENSIVE CARE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ADOLESCENT; ARTIFICIAL VENTILATION; CASE REPORT; ENDOTRACHEAL INTUBATION; FEMALE; MALE; PEDIATRICS; PRESCHOOL CHILD; PROCEDURES; STATUS ASTHMATICUS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANESTHETICS, INHALATION; ANTI-ASTHMATIC AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; ISOFLURANE; MALE; PEDIATRICS; RESPIRATION, ARTIFICIAL; STATUS ASTHMATICUS;

EID: 84926521736     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12577     Document Type: Review

References (68)

1. Cohen NH, Eigen H, Shaughnessy TE,. Status asthmaticus. Crit Care Clin 1997; 13: 459-476.
2. Masoli M, Fabian D, Holt S, et al,. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478.
3. Moorman JE, Akinbami LJ, Bailey CM, et al,. National surveillance of asthma: United States, 2001-2010. Vital Health Stat 3. 2012: 1-67.
4. Busse WW, Lemanske RF Jr,. Asthma. N Engl J Med 2001; 344: 350-362.
5. Koninckx M, Buysse C, de Hoog M,. Management of status asthmaticus in children. Paediatr Respir Rev 2013; 14: 78-85.
6. Papiris SA, Manali ED, Kolilekas L, et al,. Acute severe asthma: new approaches to assessment and treatment. Drugs 2009; 69: 2363-2391.
7. Plaza V, Serrano J, Picado C, et al,. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002; 19: 846-852.
8. Shankar V, Churchwell KB, Deshpande JK,. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med 2006; 32: 927-933.
9. Nakagawa M, Terashima T, D'Yachkova Y, et al,. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 1998; 98: 2307-2313.
10. Neonatal Hematology. Pathogenesis, Diagnosis and Management, of Hematologic Problems., Alarcon P, ed. London: Cambridge University Press; 2013: 255-256
11. Yildizdas D, Yapicioglu H, Yilmaz HL, et al,. Correlation of simultaneously obtained capillary, venous, and arterial blood gases of patients in a paediatric intensive care unit. Arch Dis Child 2004; 89: 176-180.
12. Harrison AM, Lynch JM, Dean JM, et al,. Comparison of simultaneously obtained arterial and capillary blood gases in pediatric intensive care unit patients. Crit Care Med 1997; 25: 1904-1908.
13. Chu YC, Chen CZ, Lee CH, et al,. Prediction of arterial blood gas values from venous blood gas values in patients with acute respiratory failure receiving mechanical ventilation. J Formos Med Assoc 2003; 102: 539-543.
14. Gorelick MH, Stevens MW, Schultz T, et al,. Difficulty in obtaining peak expiratory flow measurements in children with acute asthma. Pediatr Emerg Care 2004; 20: 22-26.
15. Papo MC, Frank J, Thompson AE,. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993; 21: 1479-1486.
16. Bhogal SK, McGillivray D, Bourbeau J, et al,. Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Ann Emerg Med 2012; 60: 84-91.e3.
17. Smith M, Iqbal S, Elliott TM, et al,. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev. 2003: (2) Cd002886.
18. Goggin N, Macarthur C, Parkin PC,. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med 2001; 155: 1329-1334.
19. Schuh S, Johnson DW, Callahan S, et al,. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J pediatr 1995; 126: 639-645.
20. Cheuk DK, Chau TC, Lee SL,. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005; 90: 74-77.
21. Ciarallo L, Sauer AH, Shannon MW,. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr 1996; 129: 809-814.
22. Browne GJ, Penna AS, Phung X, et al,. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997; 349: 301-305.
23. Bogie AL, Towne D, Luckett PM, et al,. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care 2007; 23: 355-361.
24. Bien JP, Bloom MD, Evans RL, et al,. Intravenous theophylline in pediatric status asthmaticus. A prospective, randomized, double-blind, placebo-controlled trial. Clin Pediatr 1995; 34: 475-481.
25. Strauss RE, Wertheim DL, Bonagura VR, et al,. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics 1994; 93: 205-210.
26. Roberts G, Newsom D, Gomez K, et al,. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 2003; 58: 306-310.
27. Wheeler DS, Jacobs BR, Kenreigh CA, et al,. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care Med 2005; 6: 142-147.
28. Mayordomo-Colunga J, Medina A, Rey C, et al,. Non-invasive ventilation in pediatric status asthmaticus: a prospective observational study. Pediatr Pulmonol 2011; 46: 949-955.
29. Kudukis TM, Manthous CA, Schmidt GA, et al,. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr 1997; 130: 217-224.
30. Bigham MT, Jacobs BR, Monaco MA, et al,. Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial. Pediatr Crit Care Med 2010; 11: 356-361.
31. Goyal S, Agrawal A,. Ketamine in status asthmaticus: a review. Indian J Crit Care Med 2013; 17: 154-161.
32. Petrillo TM, Fortenberry JD, Linzer JF, et al,. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma 2001; 38: 657-664.
33. Maddox RP, Seupaul RA,. Is ketamine effective for the management of acute asthma exacerbations in children? Ann Emerg Med 2014; 63: 309-310.
34. Youssef-Ahmed MZ, Silver P, Nimkoff L, et al,. Continuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive Care Med 1996; 22: 972-976.
35. Ouedraogo N, Roux E, Forestier F, et al,. Effects of intravenous anesthetics on normal and passively sensitized human isolated airway smooth muscle. Anesthesiology 1998; 88: 317-326.
36. Bray RJ,. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8: 491-499.
37. Becker AB, Nelson NA, Simons FE,. Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children. J Pediatr 1983; 102: 465-469.
38. Sharma A, Madan A,. Subcutaneous epinephrine vs nebulized salbutamol in asthma. Indian J Pediatr 2001; 68: 1127-1130.
39. Wiebe K, Rowe BH,. Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review. CJEM 2007; 9: 304-308.
40. Nair GB, Ilowite JS,. Pharmacologic agents for mucus clearance in bronchiectasis. Clin Chest Med 2012; 33: 363-370.
41. Chia AC, Menzies D, McKeon DJ,. Nebulised DNase post-therapeutic bronchoalveolar lavage in near fatal asthma exacerbation in an adult patient refractory to conventional treatment. BMJ Case Rep 2013; 2013. doi: 10.1136/bcr-2013-009661.
42. Hull JH, Castle N, Knight RK, et al,. Nebulised DNase in the treatment of life threatening asthma. Resuscitation 2007; 74: 175-177.
43. Durward A, Forte V, Shemie SD,. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus. Crit Care Med 2000; 28: 560-562.
44. Marquette CH, Saulnier F, Leroy O, et al,. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146: 76-81.
45. Zabrocki LA, Brogan TV, Statler KD, et al,. Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality. Crit Care Med 2011; 39: 364-370.
46. Rehder KJ, Turner DA, Cheifetz IM,. Extracorporeal membrane oxygenation for neonatal and pediatric respiratory failure: an evidence-based review of the past decade (2002-2012). Pediatric Crit Care Med 2013; 14: 851-861.
47. Turner DA, Heitz D, Cooper MK, et al,. Isoflurane for life-threatening bronchospasm: a 15-year single-center experience. Respir Care 2012; 57: 1857-1864.
48. Restrepo RD, Pettignano R, DeMeuse P,. Halothane, an effective infrequently used drug, in the treatment of pediatric status asthmaticus: a case report. J Asthma 2005; 42: 649-651.
49. Johnston RG, Noseworthy TW, Friesen EG, et al,. Isoflurane therapy for status asthmaticus in children and adults. Chest 1990; 97: 698-701.
50. Maltais F, Sovilj M, Goldberg P, et al,. Respiratory mechanics in status asthmaticus. Effects of inhalational anesthesia. Chest 1994; 106: 1401-1406.
51. Wheeler DS, Clapp CR, Ponaman ML, et al,. Isoflurane therapy for status asthmaticus in children: a case series and protocol. Pediatr Crit Care Med 2000; 1: 55-59.
52. Tobias JD,. Inhalational anesthesia: basic pharmacology, end organ effects, and applications in the treatment of status asthmaticus. J Intensive Care Med 2009; 24: 361-371.
53. Vaschetto R, Bellotti E, Turucz E, et al,. Inhalational anesthetics in acute severe asthma. Curr Drug Targets 2009; 10: 826-832.
54. von Ungern-Sternberg BS, Saudan S, Petak F, et al,. Desflurane but not sevoflurane impairs airway and respiratory tissue mechanics in children with susceptible airways. Anesthesiology 2008; 108: 216-224.
55. Kodama M, Satoh Y, Otsubo Y, et al,. Neonatal desflurane exposure induces more robust neuroapoptosis than do isoflurane and sevoflurane and impairs working memory. Anesthesiology 2011; 115: 979-991.
56. Murray JM, Trinick TR,. Plasma fluoride concentrations during and after prolonged anesthesia: a comparison of halothane and isoflurane. Anest Analg 1992; 74: 236-240.
57. Best A, Wenstone R, Murphy P,. Prolonged use of isoflurane in asthma. Can J Anaesth 1994; 41: 452-453.
58. Amos RJ, Amess JA, Hinds CJ, et al,. Investigations into the effect of nitrous oxide anaesthesia on folate metabolism in patients receiving intensive care. Chemioterapia 1985; 4: 393-399.
59. Char DS, Ibsen LM, Ramamoorthy C, et al,. Volatile anesthetic rescue therapy in children with acute asthma: innovative but costly or just costly? Pediatric Crit Care Med 2013; 14: 343-350.
60. Miyagi T, Gushima Y, Matsumoto T, et al,. Prolonged isoflurane anesthesia in a case of catastrophic asthma. Acta paediatr Jpn 1997; 39: 375-378.
61. Takeyama K, Takaya T, Takiguchi M, et al,. A case of status asthmatics relieved by long-term inhalation of isoflurane. Masui 1995; 44: 1559-1562.
62. du Peloux Menage H, Duffy S, Yates DW, et al,. Reversible sensorimotor impairment following prolonged ventilation with isoflurane and vecuronium for acute severe asthma. Thorax 1992; 47: 1078-1079.
63. Parnass SM, Feld JM, Chamberlin WH, et al,. Status asthmaticus treated with isoflurane and enflurane. Anest Analg 1987; 66: 193-195.
64. Arakawa H, Takizawa T, Tokuyama K, et al,. Efficacy of inhaled anticholinergics and anesthesia in treatment of a patient in status asthmaticus. J Asthma 2002; 39: 77-80.
65. Rice M, Hatherill M, Murdoch IA,. Rapid response to isoflurane in refractory status asthmaticus. Arch Dis Child 1998; 78: 395-396.
66. Revell S, Greenhalgh D, Absalom SR, et al,. Isoflurane in the treatment of asthma. Anaesthesia 1988; 43: 477-479.
67. Soro M, Badenes R, Garcia-Perez ML, et al,. The accuracy of the anesthetic conserving device (AnaConDa(c)) as an alternative to the classical vaporizer in anesthesia. Anest Analg 2010; 111: 1176-1179.
68. Tobias JD,. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000; 28: 2122-2132.